Figure 1.
Structures of the three SGLT2 inhibitors currently carrying FDA-approved cardiovascular indications. The parts of the molecule that constitute the pharmacophore are designated as circled by orange lines.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.